Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-Oxazolecarboxylic acid, 4,5-dihydro-2-methyl-, methylester(9CI) is a methyl ester derivative of 4,5-dihydro-2-methyl-4-oxazolecarboxylic acid, characterized by its white solid appearance and a molecular formula of C7H9NO3. With a molecular weight of 155.15 g/mol, this compound plays a significant role in organic synthesis and pharmaceutical research, serving as a building block for the creation of various compounds. Its potential biological activities and uses in the pharmaceutical industry are areas of ongoing exploration, necessitating further research and testing to fully comprehend its properties and applications.

155884-28-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 155884-28-9 Structure
  • Basic information

    1. Product Name: 4-Oxazolecarboxylicacid,4,5-dihydro-2-methyl-,methylester(9CI)
    2. Synonyms: 4-Oxazolecarboxylicacid,4,5-dihydro-2-methyl-,methylester(9CI);4,5-Dihydro-2-methyl-1,3-oxazole-4-carboxylic acid methyl ester;Ac-Thr-OMe-4,5-dihydrooxazole;methyl 2-methyl-4,5-dihydrooxazole-4-carboxylate
    3. CAS NO:155884-28-9
    4. Molecular Formula: C6H9NO3
    5. Molecular Weight: 143.14
    6. EINECS: N/A
    7. Product Categories: CARBOXYLICESTER
    8. Mol File: 155884-28-9.mol
  • Chemical Properties

    1. Melting Point: 40 °C
    2. Boiling Point: 181.0±33.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.25±0.1 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 3.70±0.70(Predicted)
    10. CAS DataBase Reference: 4-Oxazolecarboxylicacid,4,5-dihydro-2-methyl-,methylester(9CI)(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-Oxazolecarboxylicacid,4,5-dihydro-2-methyl-,methylester(9CI)(155884-28-9)
    12. EPA Substance Registry System: 4-Oxazolecarboxylicacid,4,5-dihydro-2-methyl-,methylester(9CI)(155884-28-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 155884-28-9(Hazardous Substances Data)

155884-28-9 Usage

Uses

Used in Organic Synthesis:
4-Oxazolecarboxylic acid, 4,5-dihydro-2-methyl-, methylester(9CI) is used as a key intermediate in organic synthesis for the preparation of a wide range of chemical compounds. Its unique structure allows for versatile reactions, making it a valuable component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-Oxazolecarboxylic acid, 4,5-dihydro-2-methyl-, methylester(9CI) is utilized as a building block for the development of new drugs. Its incorporation into drug molecules can potentially enhance their pharmacological properties, such as potency, selectivity, and bioavailability. 4-Oxazolecarboxylicacid,4,5-dihydro-2-methyl-,methylester(9CI)'s potential biological activities are currently under investigation, with the aim of identifying its therapeutic potential and applications in various disease conditions.
Used in Drug Development:
4-Oxazolecarboxylic acid, 4,5-dihydro-2-methyl-, methylester(9CI) is employed in drug development as a starting material for the synthesis of novel drug candidates. Its unique chemical properties and reactivity make it a promising candidate for the design of innovative therapeutic agents with improved efficacy and safety profiles.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 4-Oxazolecarboxylic acid, 4,5-dihydro-2-methyl-, methylester(9CI) is used as a structural motif in the design of new chemical entities. Its presence in a molecule can influence the overall pharmacokinetic and pharmacodynamic properties of a drug, making it an important component in the development of next-generation therapeutics.
Overall, 4-Oxazolecarboxylic acid, 4,5-dihydro-2-methyl-, methylester(9CI) is a versatile compound with applications spanning across various industries, particularly in organic synthesis and pharmaceutical research. Its potential uses in drug development and medicinal chemistry highlight its importance in the discovery and design of new therapeutic agents. Further research and testing are essential to unlock its full potential and contribute to the advancement of the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 155884-28-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,8,8 and 4 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 155884-28:
(8*1)+(7*5)+(6*5)+(5*8)+(4*8)+(3*4)+(2*2)+(1*8)=169
169 % 10 = 9
So 155884-28-9 is a valid CAS Registry Number.

155884-28-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-methyl-4,5-dihydro-1,3-oxazole-4-carboxylate

1.2 Other means of identification

Product number -
Other names 4,5-Dihydro-2-methyl-1,3-oxazole-4-carboxylic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:155884-28-9 SDS

155884-28-9Relevant articles and documents

The synthesis of novel disorazoles

Schaeckel, Romy,Hinkelmann, Bettina,Sasse, Florenz,Kaiesse, Markus

, p. 1619 - 1622 (2010)

Big little brother: The simplified disorazole analogue 1 exhibits its cytotoxic activity at low nanomolar concentrations and provides selectivities not observed for the parent natural product.

POLYMYXIN ANALOGS USEFUL AS ANTIBIOTIC POTENTIATORS

-

Paragraph 0149, (2017/12/09)

The disclosure provides compounds of the formula (I) or a tautomer thereof, or a pharmaceutically acceptable salt of either of the foregoing. The variables A, R1, and R2 are defined in the disclosure. The disclosure further includes pharmaceutical compositions comprising a compound of formula I together with at least one pharmaceutically acceptable carrier. The disclosure also includes a method of sensitizing bacteria to an antibacterial agent, comprising administering to a patient infected with the bacteria, simultaneously or sequentially, a therapeutically effective amount of the antibacterial agent and a compound of formula (I).

PYRROLE ANTIFUNGAL AGENTS

-

Page/Page column 152, (2009/12/05)

The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.

Oxidative rearrangements of isobenzofurans: Studies toward the synthesis of the ajudazols

Hobson, Stephen J.,Parkin, Andrew,Marquez, Rodolfo

supporting information; experimental part, p. 2813 - 2816 (2009/05/27)

(Chemical Equation Presented) We present a new facet of isobenzofuran chemistry which allows for its efficient manipulation to generate biologically relevant entities. This methodology has been successfully applied toward the synthesis of ajudazol A.

Large-scale preparation of 2-methyloxazole-4-carboxaldehyde

Benoit, Georges-Emmanuel,Carey, John S.,Chapman, Alan M.,Chima, Ranjit,Hussain, Nigel,Popkin, Matthew E.,Roux, Guillaume,Tavassoli, Bahareh,Vaxelaire, Carine,Webb, Michael R.,Whatrup, David

, p. 88 - 95 (2012/12/31)

The large-scale preparation of 2-methyloxazole-4-carboxaldehyde presents a significant challenge due to the physical characteristics of the molecule. A method for the preparation of 10-kg batches of 2-methyloxazole-4-carboxaldehyde is described. The key reaction is the reduction of the corresponding N-methoxy-N-methyl amide using lithium aluminium hydride, followed by workup and isolation by crystallization.

Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol- 4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications

Iso, Yasuyoshi,Grajkowska, Ewa,Wroblewski, Jarda T.,Davis, Jared,Goeders, Nicholas E.,Johnson, Kenneth M.,Sanker, Subramaniam,Roth, Bryan L.,Tueckmantel, Werner,Kozikowski, Alan P.

, p. 1080 - 1100 (2007/10/03)

Recent genetic and pharmacological studies have suggested that the metabotropic glutamate receptor subtype 5 (mGluR5) may represent a druggable target in identifying new therapeutics for the treatment of various central nervous system disorders including drug abuse. In particular, considerable attention in the mGluR5 field has been devoted to identifying ligands that bind to the allosteric modulatory site, distinct from the site for the primary agonist glutamate. Both 2-methyl-6-(phenylethynyl)pyridine (MPEP) and its analogue 3-[(2-methyl-4-thiazolyl)ethynyl]pyridine (MTEP) have been shown to be selective and potent noncompetitive antagonists of mGluR5. Because of results presented in this study showing that MTEP prevents the reinstatement of cocaine self-administration caused by the presentation of environmental cues previously associated with cocaine availability, we have prepared a series of analogues of MTEP with the aim of gaining a better understanding of the structural features relevant to its antagonist potency and with the ultimate aim of investigating the effects of such compounds in blunting the self-administration of cocaine. These efforts have led to the identification of compounds showing higher potency as mGluR5 antagonists than either MPEP or MTEP. Two compounds 19 and 59 exhibited functional activity as mGluR5 antagonists that are 490 and 230 times, respectively, better than that of MTEP.

Synthesis of 4-arylethynyl-2-methyloxazole derivatives as mGluR5 antagonists for use in the treatment of drug abuse

Iso, Yasuyoshi,Kozikowski, Alan P.

, p. 243 - 246 (2007/10/03)

In structure-activity relationship studies directed toward the use of mGluR5 antagonists in the treatment of drug abuse, we sought a convenient means for gaining access to the oxazole analogues of MTEP. Toward this end, the aldehyde group in 2-methyloxazo

Oxidation of oxazolines and thiazolines to oxazoles and thiazoles. Application of the Kharasch-Sosnovsky reaction

Meyers,Tavares, Francis X.

, p. 8207 - 8215 (2007/10/03)

Using a modification of the Kharasch-Sosnovsky reaction, the oxidation of oxazolines and thiazolines bearing a variety of 2-alkyl substituents (chiral and achiral) were smoothly oxidized to their corresponding oxazoles and thiazoles, respectively. The key feature involved in the successful implementation of this important oxidation was the use of a mixture of Cu(I) and Cu(II) salts to enhance the oxidation of the intermediate captodative radical, 24. The main limitation of this method was shown when the oxidation failed with oxazolines/thiazolines lacking the carboalkoxy group at C-4.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 155884-28-9